Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A J G van den Brand

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|December 14, 2011
Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathyJan A J G van den Brand, Julia M Hofstra, Jack F M Wetzels
Clinical Journal of the American Society of Nephrology : CJASN|May 19, 2012
Prognostic value of risk score and urinary markers in idiopathic membranous nephropathyJan A J G van den Brand, Julia M Hofstra, Jack F M Wetzels
Journal of the American Society of Nephrology : JASN|October 29, 2011
Segmental and global subclasses of class IV lupus nephritis have similar renal outcomesCatharina M Haring, Anke Rietveld, Jan A J G van den Brand, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2017
Statistical significance versus clinical relevanceMarieke H C van Rijn, Anneke Bech, Jean Bouyer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2017
Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndromeJan A J G van den Brand, Jacobien C Verhave, Eddy M Adang, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 31, 2017
Graft intolerance syndrome requiring graft nephrectomy after late kidney graft failure: can it be predicted? A retrospective cohort studyKim L W Bunthof, Carmen M Verhoeks, Jan A J G van den Brand, et al.
Journal of the American Society of Nephrology : JASN|September 14, 2013
Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategyJan A J G van den Brand, Peter R van Dijk, Julia M Hofstra, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 24, 2014
Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathyJan A J G van den Brand, Peter R van Dijk, Julia M Hofstra, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 7, 2017
Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patientsDebbie Zittema, Jan A J G van den Brand, Stephan J L Bakker, et al.
Kidney International Reports|December 11, 2020
Worldwide Disparity in the Relation Between CKD Prevalence and Kidney Failure RiskMarieke H C van Rijn, Natalia Alencar de Pinho, Jack F Wetzels, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical Journal of the American Society of Nephrology : CJASN|December 14, 2011
Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathyJan A J G van den Brand, Julia M Hofstra, Jack F M Wetzels
Clinical Journal of the American Society of Nephrology : CJASN|May 19, 2012
Prognostic value of risk score and urinary markers in idiopathic membranous nephropathyJan A J G van den Brand, Julia M Hofstra, Jack F M Wetzels
Journal of the American Society of Nephrology : JASN|October 29, 2011
Segmental and global subclasses of class IV lupus nephritis have similar renal outcomesCatharina M Haring, Anke Rietveld, Jan A J G van den Brand, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2017
Statistical significance versus clinical relevanceMarieke H C van Rijn, Anneke Bech, Jean Bouyer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2017
Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndromeJan A J G van den Brand, Jacobien C Verhave, Eddy M Adang, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 31, 2017
Graft intolerance syndrome requiring graft nephrectomy after late kidney graft failure: can it be predicted? A retrospective cohort studyKim L W Bunthof, Carmen M Verhoeks, Jan A J G van den Brand, et al.
Journal of the American Society of Nephrology : JASN|September 14, 2013
Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategyJan A J G van den Brand, Peter R van Dijk, Julia M Hofstra, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 24, 2014
Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathyJan A J G van den Brand, Peter R van Dijk, Julia M Hofstra, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 7, 2017
Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patientsDebbie Zittema, Jan A J G van den Brand, Stephan J L Bakker, et al.
Kidney International Reports|December 11, 2020
Worldwide Disparity in the Relation Between CKD Prevalence and Kidney Failure RiskMarieke H C van Rijn, Natalia Alencar de Pinho, Jack F Wetzels, et al.
Pageof 3